Morimoto C - Search Results

1

A possible role for CD26/DPPIV enzyme activity in the regulation of psoriatic pruritus.

Komiya E, Hatano R, Otsuka H, Itoh T, Yamazaki H, Yamada T, Dang NH, Tominaga M, Suga Y, Kimura U, Takamori K, Morimoto C, Ohnuma K. Komiya E, et al. Among authors: morimoto c. J Dermatol Sci. 2017 Jun;86(3):212-221. doi: 10.1016/j.jdermsci.2017.03.005. Epub 2017 Mar 10. J Dermatol Sci. 2017. PMID: 28365081

2

Cloning and functional expression of the T cell activation antigen CD26.

Tanaka T, Camerini D, Seed B, Torimoto Y, Dang NH, Kameoka J, Dahlberg HN, Schlossman SF, Morimoto C. Tanaka T, et al. Among authors: morimoto c. J Immunol. 1992 Jul 15;149(2):481-6. J Immunol. 1992. PMID: 1352530

3

Biochemical characterization of CD26 (dipeptidyl peptidase IV): functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies.

Torimoto Y, Dang NH, Tanaka T, Prado C, Schlossman SF, Morimoto C. Torimoto Y, et al. Among authors: morimoto c. Mol Immunol. 1992 Feb;29(2):183-92. doi: 10.1016/0161-5890(92)90099-j. Mol Immunol. 1992. PMID: 1371820

4

Good or evil: CD26 and HIV infection.

Ohtsuki T, Tsuda H, Morimoto C. Ohtsuki T, et al. Among authors: morimoto c. J Dermatol Sci. 2000 Apr;22(3):152-60. doi: 10.1016/s0923-1811(99)00081-x. J Dermatol Sci. 2000. PMID: 10698152 Review.

5

In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299.

Ho L, Aytac U, Stephens LC, Ohnuma K, Mills GB, McKee KS, Neumann C, LaPushin R, Cabanillas F, Abbruzzese JL, Morimoto C, Dang NH. Ho L, et al. Among authors: morimoto c. Clin Cancer Res. 2001 Jul;7(7):2031-40. Clin Cancer Res. 2001. PMID: 11448921

6

Expression of CD26 and its associated dipeptidyl peptidase IV enzyme activity enhances sensitivity to doxorubicin-induced cell cycle arrest at the G(2)/M checkpoint.

Aytac U, Claret FX, Ho L, Sato K, Ohnuma K, Mills GB, Cabanillas F, Morimoto C, Dang NH. Aytac U, et al. Among authors: morimoto c. Cancer Res. 2001 Oct 1;61(19):7204-10. Cancer Res. 2001. PMID: 11585756

7

CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO.

Ishii T, Ohnuma K, Murakami A, Takasawa N, Kobayashi S, Dang NH, Schlossman SF, Morimoto C. Ishii T, et al. Among authors: morimoto c. Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12138-43. doi: 10.1073/pnas.211439098. Epub 2001 Oct 2. Proc Natl Acad Sci U S A. 2001. PMID: 11593028 Free PMC article.

8

Soluble CD26/dipeptidyl peptidase IV induces T cell proliferation through CD86 up-regulation on APCs.

Ohnuma K, Munakata Y, Ishii T, Iwata S, Kobayashi S, Hosono O, Kawasaki H, Dang NH, Morimoto C. Ohnuma K, et al. Among authors: morimoto c. J Immunol. 2001 Dec 15;167(12):6745-55. doi: 10.4049/jimmunol.167.12.6745. J Immunol. 2001. PMID: 11739489

9

Soluble CD26/dipeptidyl peptidase IV enhances transendothelial migration via its interaction with mannose 6-phosphate/insulin-like growth factor II receptor.

Ikushima H, Munakata Y, Iwata S, Ohnuma K, Kobayashi S, Dang NH, Morimoto C. Ikushima H, et al. Among authors: morimoto c. Cell Immunol. 2002 Jan;215(1):106-10. doi: 10.1016/s0008-8749(02)00010-2. Cell Immunol. 2002. PMID: 12142042

10

Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus.

Kobayashi H, Hosono O, Mimori T, Kawasaki H, Dang NH, Tanaka H, Morimoto C. Kobayashi H, et al. Among authors: morimoto c. J Rheumatol. 2002 Sep;29(9):1858-66. J Rheumatol. 2002. PMID: 12233879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

534 results

Search Page

Filters